1. Home
  2. AAOI vs GERN Comparison

AAOI vs GERN Comparison

Compare AAOI & GERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AAOI
  • GERN
  • Stock Information
  • Founded
  • AAOI 1997
  • GERN 1990
  • Country
  • AAOI United States
  • GERN United States
  • Employees
  • AAOI N/A
  • GERN N/A
  • Industry
  • AAOI Semiconductors
  • GERN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AAOI Technology
  • GERN Health Care
  • Exchange
  • AAOI Nasdaq
  • GERN Nasdaq
  • Market Cap
  • AAOI 1.5B
  • GERN 1.5B
  • IPO Year
  • AAOI 2013
  • GERN 1996
  • Fundamental
  • Price
  • AAOI $16.38
  • GERN $1.65
  • Analyst Decision
  • AAOI Buy
  • GERN Buy
  • Analyst Count
  • AAOI 4
  • GERN 11
  • Target Price
  • AAOI $32.25
  • GERN $5.80
  • AVG Volume (30 Days)
  • AAOI 5.0M
  • GERN 14.9M
  • Earning Date
  • AAOI 05-08-2025
  • GERN 05-01-2025
  • Dividend Yield
  • AAOI N/A
  • GERN N/A
  • EPS Growth
  • AAOI N/A
  • GERN N/A
  • EPS
  • AAOI N/A
  • GERN N/A
  • Revenue
  • AAOI $249,365,000.00
  • GERN $76,994,000.00
  • Revenue This Year
  • AAOI $113.96
  • GERN $208.83
  • Revenue Next Year
  • AAOI $48.75
  • GERN $57.49
  • P/E Ratio
  • AAOI N/A
  • GERN N/A
  • Revenue Growth
  • AAOI 14.57
  • GERN 32386.92
  • 52 Week Low
  • AAOI $6.70
  • GERN $1.46
  • 52 Week High
  • AAOI $44.50
  • GERN $5.34
  • Technical
  • Relative Strength Index (RSI)
  • AAOI 38.63
  • GERN 34.01
  • Support Level
  • AAOI $19.65
  • GERN $1.63
  • Resistance Level
  • AAOI $22.77
  • GERN $1.89
  • Average True Range (ATR)
  • AAOI 1.93
  • GERN 0.11
  • MACD
  • AAOI 0.18
  • GERN 0.04
  • Stochastic Oscillator
  • AAOI 24.69
  • GERN 21.87

About AAOI Applied Optoelectronics Inc.

Applied Optoelectronics Inc is a provider of fiber-optic networking products for the Internet data center, cable television, telecommunications and fiber-to-the-home end markets. The company focuses on designing and manufacturing a range of optical communication products from components, to subassemblies, and modules to complete turn-key equipment. Demand for Applied Optoelectronics is driven by bandwidth demand in end markets. Through direct sales personnel, and manufacturing teams in the United States, China, and Taiwan, the company coordinates with customers to determine product design, qualifications, and performance. The company derives maximum revenue from Taiwan.

About GERN Geron Corporation

Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Share on Social Networks: